Squire Patton Boggs Advises Baird Capital on Investment in Life Sciences Consultancy Newmarket Strategy
January 10, 2025
January 10, 2025
TYSONS, Virginia, Jan. 10 -- Squire Patton Boggs, a law firm, issued the following news:
Squire Patton Boggs has advised Baird Capital on a growth capital investment in Newmarket Strategy, an independent life sciences consultancy and market access specialist. The investment will support the company's continued growth as an independent leader in pharmaceutical services and healthcare advisory.
The Squire Patton Boggs team advising Baird Capital was led by Corporate . . .
Squire Patton Boggs has advised Baird Capital on a growth capital investment in Newmarket Strategy, an independent life sciences consultancy and market access specialist. The investment will support the company's continued growth as an independent leader in pharmaceutical services and healthcare advisory.
The Squire Patton Boggs team advising Baird Capital was led by Corporate . . .